Mona Lisa Alattar

Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation

Farhad Ravandi, Mona Lisa Alattar, Michael R. Grunwald et al. · Blood · 2013 · 378 citations

Medicine, Oncology, Pharmacotherapy +12

Portal Hypertension Associated With Oxaliplatin Administration: Clinical Manifestations of Hepatic Sinusoidal Injury

Julian H. Slade, Mona Lisa Alattar, David R. Fogelman et al. · Clinical Colorectal Cancer · 2009 · 112 citations

Medicine, Internal Medicine, Oncology +17

Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: retrospective analysis of patient data from five clinical trials

Preetesh Jain, Hagop M. Kantarjian, Mona Lisa Alattar et al. · The Lancet Haematology · 2015 · 82 citations · Full text

Medicine, Hematology, Pharmacology +17

Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase

Maro Ohanian, Hagop M. Kantarjian, Alfonso Quintás‐Cardama et al. · Clinical Lymphoma Myeloma & Leukemia · 2013 · 56 citations

Medicine, Hematology, Oncology +17

Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation

Maro Ohanian, Carlos E. Bueso‐Ramos, Chi Young Ok et al. · Cancer Genetics · 2015 · 12 citations · Full text

Medicine, Genetics, Hematology +16